COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases.

Abstract

We read with interest the letter published by Bozzalla Cassione et al, 1 in which authors evaluated 165 patients with systemic lupus erythematosus using telemedicine as the follow-up method. As in Italy, the high infectivity and the risk of collapse of intensive care units led to the Spanish government to announce on 14 March the strict confinement and prohibition of social mobility to ensure a decrease in COVID-19 contagion rates.